Coronaviruses
The World's First International Journal Dedicated to Coronaviruses
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Aims & Scope
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.
Coronaviruses
,Volume 2
-Number 6
Letter to the Editor Open Access
COVID-19: A Daily Dose of Yoga to Cope with Anxiety
, 2(6): e280521188251Surabhi Gautam and Rima Dada*
DOI: 10.2174/2666796701999201123102216
COVID-19: A Daily Dose of Yoga to Cope with Anxiety
Perspective Open Access
COVID-19 Effect: Time to Change the Way of Research
, 2(6): e280521188049Vikas Sharma*
DOI: 10.2174/2666796701999201116212443
COVID-19 Effect: Time to Change the Way of Research
Perspective Article Open Access
A Study About the Impact of Weather, Life Expectancy and Tourism on the Transmission of COVID-19
, 2(6): e280521186888Pardeep Bishnoi, Prabhat Kumar*, Abhijeet Singh, Mukesh Kumar Sahu and Vikrant Bansal
DOI: 10.2174/2666796701999201014155715
A Study About the Impact of Weather, Life Expectancy and Tourism on the Transmission of COVID-19
Review Article Open Access
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19
, 2(6): e280521189255Carolina Restini*, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim and Courtney Merlo
DOI: 10.2174/2666796701999201218141035
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19
Review Article Open Access
Novel Coronavirus Disease 2019 (COVID-19) Current Update: Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines
, 2(6): e020621187754Sunil L. Harer* and Priyanka A. Sonar
DOI: 10.2174/2666796701999201109213553
Novel Coronavirus Disease 2019 (COVID-19) Current Update: Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines
Review Article Open Access
Comprehensive Review on Epidemiology, Diagnosis and Auspicious Management of COVID 19
, 2(6): e020621187086Pratibha Auti*, Sagar Kothawade, Anagha Soundankar and Vinayak Kumbhar
DOI: 10.2174/2666796701999201021150744
Comprehensive Review on Epidemiology, Diagnosis and Auspicious Management of COVID 19
Review Article Open Access
The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
, 2(6): e130621188923Onome Ejeromedoghene*, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo and Richard O. Akinyeye*
DOI: 10.2174/2666796701999201209142419
The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
Review Article (Mini-Review) Open Access
Mechanism of Action of Chloroquine/Hydroxychloroquine for Covid-19 Infection
, 2(6): e130621187910Alberto Boretti*, Bimal Banik and Stefania Castelletto
DOI: 10.2174/2666796701999201112125319
Mechanism of Action of Chloroquine/Hydroxychloroquine for Covid-19 Infection
Coronaviruses, Volume 2 (2021) - Number 7
This issue is in progress but contains articles that are final and fully citable.
Articles Ahead of Print
SARS-CoV-2: Molecular Biology and Therapeutic Targets
Vivek Pandey, Ankita Pathak, Mohammad Shahar Yar and Yuba Raj Pokharel*
DOI: 10.2174/2666796702666210225103821
View Abstract
Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
Asim Azhar*, Khaled Al-hosaini, Parvez Anwar Khan, Abdul M Oanz, Qamar Zia, Saeed Banawas, Jae-Jung Dong, Mohammad Amjad Kamal and Mohammad Owais
DOI: 10.2174/2666796702666210202125638
View Abstract
World’s Proposed Safeguard Against COVID-19 – A Brief Review
Sumanta Dey*, Anindita Dey, Shreyans Chatterjee, Papiya Nandy and Ashesh Nandy
DOI: 10.2174/2666796702666210223160304
View Abstract
A Mini Review on COVID-19 Therapeutics: Current Status and Future Directions
Niranjan Kaushik, Vikram Sharma and Vikas Sharma*
DOI: 10.2174/2666796702999210111224941
View Abstract
Immunological Response of the Respiratory Tract in the SARS-CoV-2 Infection
Sanjiv Singh*, Punita Aggarwal and Velayutham Ravichandiran
DOI: 10.2174/2666796702666210216143545
View Abstract
Effect of miRNAs, Proinflammatory Cytokines and ACE2 in COVID-19 Pathophysiology
Hari Om Singh*, Kamini Jakhar, Vijay Nema, Asha Krishnaraj and Ranjana Choudhari
DOI: 10.2174/2666796702666210303114330
View Abstract
Withdrawal Notice: Global Comprehensive Outlook of Hantavirus Contagion on Humans: A Review
Sumel Ashique, Navjot K Sandhu*, Supratim Das, Sk. Niyamul Haque and Kartick Koley
DOI: 10.2174/2666796701999200922091340
View Abstract
Functionalized Photocatalytic Nanocoatings for Inactivating COVID-19 Virus Residing on Surfaces of Public and Healthcare Facilities
Manjunatha Channegowda *, Hassler Bueno Garcia and Itthipon Jeerapan*
DOI: 10.2174/2666796702666210222110403
View Abstract
Abstracts Ahead of Print
COVID-19 Vaccines: Fabrication Techniques and Current Status
Ayushi Mahajan, Lakhvir Kaur*, Gurjeet Singh, RK Dhawan, Lovepreet Singh and Anureet Kaur
DOI: 10.2174/2666796702666210728150704
View Abstract
Anti-COVID-19 Sulfonamides: A DFT, docking and ADMET study
Ashique Al Hoque, Chayan Guha, Nayim Sepay, Sankar P Dey and Umesh C Halder*
DOI: 10.2174/2666796702666210719103409
View Abstract
SARS-CoV-2: Evaluation and Evolution
Loay Bedda, Fayrouz Mahmoud*, Radwa Elkhateib*, Alyaa Dawoud, Hassan Gamal, Abdallah S. Abdelsattar and Ayman El-Shibiny*
DOI: 10.2174/2666796702666210712104119
View Abstract
Identification of flavonoids as potent inhibitors against MERS‐CoV 3C‐like protease
Fatemeh Abdi and Shahrzad Javanshir*
DOI: 10.2174/2666796702666210709115659
View Abstract
Immunosuppressant Drugs And Covid-19: Associated Risks, Drug-Drug Interactions & Contraindications
Debjyoti Talukdar, Diane Ignacio and Madan Mohan Gupta*
DOI: 10.2174/2666796702666210601125131
View Abstract
Graphene versus coronavirus: A study of the graphene properties that can help to combat coronavirus
T. Guerra*, I. O. Assis and A. B. Guerra
DOI: 10.2174/2666796702666210329143841
View Abstract
Detection of Viruses: insides of antibody-antigen interactions and Multifunctional Lab-On-particle for SARS CoV-2 detection
Martin Amé, Esraa Samy Abu Serea, Ahmed Esmail Shalan and A. Guillermo Bracamonte*
DOI: 10.2174/2666796702666210329142505
View Abstract
Lipid lowering natural products targeting hPCSK9 may prevent the severity of COVID-19 infection
Ajoy Basak*, Jaishree Vaijanathappa and Sarmistha Basak
DOI: 10.2174/2666796702666210329141042
View Abstract
New Perspectives for SARS-CoV-2 Rapid Detection
Latifa Khattabi*, Mustapha Mounir Bouhenna and Feriel Sellam
DOI: 10.2174/2666796702666210308114737
View Abstract
Antimicrobial Resistance: The Potent Enemy Lurking Behind COVID-19
Rohini Kanwar, Amit Kumar, Jyoti Rathee and Surinder K. Mehta*
DOI: 10.2174/2666796702666210224125409
View Abstract
Published Contents
Editor's Choice
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19
, 2021; 2(6): 4 - 16Carolina Restini*, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim and Courtney Merlo
DOI: 10.2174/2666796701999201218141035
The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review
, 2021; 2(5): 1 - 10Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, Md Sarfraz, Nawshad Muhammad and Syed A.A. Rizvi*
DOI: 10.2174/2666796701999201123101730
Emergence of a New Zoonotic COVID-19 that Creates a Pandemic: Update on Current Pharmacotherapeutics and Future Prospective of Plasma Therapy
, 2021; 2(4): 422 - 430Farazul Hoda, Rishabh Verma, Saurabh Rastogi, Asif Iqubal, Syed Ehtaishamul Haque, Mohd. Akhtar and Abul Kalam Najmi*
DOI: 10.2174/2666796701999201014160857
Current Advances in Novel SARS-CoV-2 Disease (COVID-19) Treatment and Intervention Strategies
, 2021; 2(3): 353 - 358Mohammad Khalid Parvez* and Kartika Padhan
DOI: 10.2174/2666796701999201116125249
Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
, 2021; 2(2): 151 - 158Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200713191436
Vitamin D3 Deficiency and COVID-19
, 2021; 2(1): 2 - 3Olen R. Brown* and Martin R. Hullender
DOI: 10.2174/2666796701999200914112352
Potential Drug Options for Treatment of COVID-19: A Review
, 2020; 1(1): 42 - 48Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200701131604
Open Access Articles
The Outbreak of Coronavirus Disease 2019 (COVID-19) and its Manifestation
, 2021; 2(7): 8 - 14Bikash Debnath, Waikhom Somraj Singh and Kuntal Manna*
Recent developments and opportunities in fighting COVID-19
, 2021; 2(7): 7 - 17Vikram Rao and Subrat Kumar Bhattamisra*
Coronavirus Pandemic: Role of Bats And Zoonotic Transmission in Humans
, 2021; 2(7): 6 - 16Baljinder Singh, Jasleen Kaur and Sumeet Gupta*
A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
, 2021; 2(7): 5 - 20Sumel Ashique, Navjot K. Sandhu*, Sk. Niyamul Haque and Kartick Koley
COVID-19: How Nuclear Medicine Can Provide A Differential Diagnosis In A Very Dubious Case
, 2021; 2(7): 2 - 4Maria Silvia De Feo, Viviana Frantellizzi* and Giuseppe De Vincentis
Is There Any Role of IL-6 Inhibition in COVID-19?
, 2021; 2(7): 1 - 6Rebecca Cannon and Satyajit Das*
Safety and Efficacy of Convalescent Plasma Therapy for the Management of COVID-19: A Systematic Review
, 2021; 2(6): 9 - 18Sitaram Khadka*, Mohammad Saleem, Dhan Bahadur Shrestha and Pravash Budhathoki
Mechanism of Action of Chloroquine/Hydroxychloroquine for Covid-19 Infection
, 2021; 2(6): 8 - 17Alberto Boretti*, Bimal Banik and Stefania Castelletto
The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
, 2021; 2(6): 7 - 18Onome Ejeromedoghene*, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo and Richard O. Akinyeye*
Comprehensive Review on Epidemiology, Diagnosis and Auspicious Management of COVID 19
, 2021; 2(6): 6 - 18Pratibha Auti*, Sagar Kothawade, Anagha Soundankar and Vinayak Kumbhar
Novel Coronavirus Disease 2019 (COVID-19) Current Update: Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines
, 2021; 2(6): 5 - 27Sunil L. Harer* and Priyanka A. Sonar
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19
, 2021; 2(6): 4 - 16Carolina Restini*, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim and Courtney Merlo
A Study About the Impact of Weather, Life Expectancy and Tourism on the Transmission of COVID-19
, 2021; 2(6): 3 - 8Pardeep Bishnoi, Prabhat Kumar*, Abhijeet Singh, Mukesh Kumar Sahu and Vikrant Bansal
History and Global Status of the New Coronavirus Covid-2019 and Aspects of Previous Infections of SARS-CoV and MERS-CoV: A Systematic Review
, 2021; 2(6): 10 - 18Amanda Pinato Alves da Costa*, Vinicius Lisboa da Rocha, Rogério Rodrigo Ramos, José Martins Pinto Neto, Wagner Rafael da Silva, Luis Lenin Vicente Pereira, Kelys Ramos, Tais Cristina Nascimento Marques, Idiberto José Zotarelli Filho and André Wilian Lozano
Most Cited Articles
Most Accessed Articles
Is COVID-19 a Systemic Disease?
, 2021; 2(5): 4-8.Sherif Mohamed*, Khaled Saad, Ghada Elgohary, Azza AbdElHaffez and Nashwa Abd El-Aziz
DOI: 10.2174/2666796701999201216101914
Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
, 2021; 2(1): 6-7.Zeynep Gunes Ozunal and Sevki Sahin*
DOI: 10.2174/2666796701999200713192912
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
, 2020; 1(1): 4-6.Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
DOI: 10.2174/2666796701999200629003417
Coronavirus: History, Genome Structure and Pathogenesis
, 2021; 2(3): 325-338.B. Poonam and Prabhjot Kaur Gill*
DOI: 10.2174/2666796701999200918160354
The COVID-19 and Ageism in Social Media
, 2020; 1(1): 7-8.Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200621203144
Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
, 2021; 2(1): 8-10.Frans J. Walther* and Alan J. Waring
DOI: 10.2174/2666796701999201014160428
Natural Products as Anti-COVID-19 Agents: An In Silico Study
, 2021; 2(5): 10-17.Chandan Sarkar, Sarmin Jamaddar, Milon Mondal, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam* and Mohammad S. Mubarak*
DOI: 10.2174/2666796701999201116124851
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
, 2020; 1(1): 13-22.Rajagopal Kalirajan*
DOI: 10.2174/2666796701999200625210746
SARS-CoV-2 Therapy: Old Drugs as New Interventions
, 2021; 2(2): 142-150.Puneet K. Samaiya* and Mahendra Kumar
DOI: 10.2174/2666796701999200721003212
SARS-CoV-2 and its Predicted Potential Natural Inhibitors: A Review and Perspective
, 2021; 2(5): 7-20.Priyanka Samji*, Manoj Kumar Rajendran and Vidya P. Warrier
DOI: 10.2174/2666796701999200831105801
COVID-19 Pandemic: Care for Indian Cancer Patients
, 2021; 2(4): 403-404.Sandeep Kumar*
DOI: 10.2174/2666796701999201026205030
Prediction of Infection and Death Ratio of COVID-19 Virus in Turkey by Using Artificial Neural Network (ANN)
, 2021; 2(1): 106-112.Andaç Batur Çolak*
DOI: 10.2174/2666796701999200915142539
A Mini Review: Origin, Treatments, Preventions, Real Facts and Viability of the Recent Pandemic of Novel Coronavirus-2019
, 2021; 2(5): 9-14.Prashant Kantrao Vibhute, Satish Babulal Jadhav, Satish Ashruba Dake and Bhaskar Sadashiv Dawane*
DOI: 10.2174/2666796701999200826114852
Dealing with COVID-19: Lessons Learned from the Italian Experience
, 2021; 2(1): 27-29.Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
DOI: 10.2174/2666796701999200908094136
An Overview of the Treatment Contributions Measured Globally for the COVID-19 Outbreak
, 2021; 2(2): 198-203.Sheikh Saba Naz and Iqra Munir*
DOI: 10.2174/2666796701999201019154537
Editor-in-Chief
Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
(France)
Biography
Institute of NeuroPhysiopathology
Marseille, Cedex
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
Honorary Senior Advisors
Ferid Murad
(USA)
Atta-ur-Rahman, FRS
(UK)
About the Journal
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net